Glivec 400 mg Tablet
| Brand Name | Glivec |
|---|---|
| Composition (Generic / INN) | Imatinib |
| Strength | 400 mg |
| Packaging Size | 90 Tablet |
| Dosage Form | Tablet |
| Manufacturer | Novartis |
| Usage / Indication | Treat cancer of the blood |
| Minimum Order Quantity | 1 Stripe |
Glivec 400 mg Tablet — Imatinib
Glivec 400 mg Tablet is an oncology product manufactured by Novartis, with Imatinib as the active ingredient. Supplied product information indicates use in the treatment of certain blood cancers. This formulation is available in a pack of 90 tablets.
Gravity Global Export offers this product for B2B pharmaceutical export to licensed distributors, hospitals, specialty pharmacies, oncology clinics, and registered importers. We ensure batch-traceable sourcing and professional handling for international wholesale supply.
Product Details
- Brand Name: Glivec
- Active Ingredient: Imatinib
- Strength: 400 mg per tablet
- Form: Tablet
- Pack Size: 90 tablets
- Manufacturer: Novartis
- Minimum Order Quantity: 1 stripe
This medication is part of our Oncology & Cytotoxics export portfolio. Shipments are prepared in accordance with standard pharmaceutical export documentation and appropriate storage or handling requirements.
Contact Gravity Global Export today to request a quotation, confirm availability, and discuss your wholesale or institutional procurement requirements.
Interested in this product?
Tell us your quantity and destination — our export team replies with a competitive quotation.